-10%
,

Kirkland Signature Minoxidil Hair Regrowth Treatment (Extra Strength for Men) Full Pack


Regrow stronger and thicker hair with Leeza.lk Premium Quality Kirkland Signature Minoxidil Hair Regrowth Treatment (Extra Strength for Men) ????

Clinically proven 5% Minoxidil formula that helps reduce hair loss and promote hair regrowth.

???? Free nozzle applicator included with the full pack
???? Cash on Delivery Available across Sri Lanka.

රු23,490 රු26,100

3 X Rs. 7,830.00 or 6% Cashback with mintpay_info_icon_woocommerce

or 3 X රු7,830.00 with Koko
or up to 4 X රු5,872.50 with Payzy Payzy

Kirkland Signature Minoxidil Hair Regrowth Treatment (Extra Strength for Men) is a clinically proven solution designed to help regrow hair and slow down hair loss caused by hereditary hair thinning. Formulated with 5% Minoxidil, this powerful treatment works by stimulating hair follicles and improving blood flow to the scalp, helping promote thicker and stronger hair growth over time.

This full pack includes a free nozzle applicator, making it easier to apply the solution directly to the scalp for precise and effective use. With consistent use, it helps revitalize hair follicles and improve overall hair density.

Benefits

  • Contains 5% Minoxidil for effective hair regrowth

  • Helps slow down hair loss and thinning hair

  • Stimulates hair follicles to promote thicker hair

  • Improves scalp circulation for healthier hair growth

  • Includes free nozzle applicator for easy application

How to Use
Apply 1ml of the solution directly to the scalp in the hair thinning area.
Use twice daily (morning and night) for best results.
Gently massage into the scalp and allow it to dry completely.
Continuous use for at least 3–4 months is recommended to see visible results.

Ingredients
Minoxidil 5%, Alcohol, Propylene Glycol, Purified Water.

Weight 0.5 kg

Based on 0 reviews

0.0 overall
0
0
0
0
0

Be the first to review “Kirkland Signature Minoxidil Hair Regrowth Treatment (Extra Strength for Men) Full Pack”

There are no reviews yet.